APO Research
Talk to an analyst

APO RESEARCH · REPORT

Sleeping Pills (Prescription Drugs)

Compare research editions
View pricing & licenses

Selected research

Market Structure

Global Sleeping Pills (Prescription Drugs) Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032

26 December 2025190 pages

Choose your research edition.

Industry ResearchSleeping Pills (Prescription Drugs) Industry Research Report 2026121 pages · $2,950 USDIndustry Growth & TrendsGlobal Sleeping Pills (Prescription Drugs) Industry Growth and Trends Forecast to 2032107 pages · $3,450 USDMarket StructureGlobal Sleeping Pills (Prescription Drugs) Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032190 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Sleeping Pills (Prescription Drugs) Market Outlook and Growth Opportunities 2026191 pages · $4,250 USDMarket Analysis & ForecastGlobal Sleeping Pills (Prescription Drugs) Market Analysis and Forecast 2026-2032191 pages · $4,950 USD

Market perspective

The global Sleeping Pills (Prescription Drugs) market is projected to grow from US$ million in 2026 to US$ million by 2032, implying a CAGR of % over 2026-2032.

The US & Canada market for Sleeping Pills (Prescription Drugs) is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The Europe market for Sleeping Pills (Prescription Drugs) is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for Sleeping Pills (Prescription Drugs) is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The China market for Sleeping Pills (Prescription Drugs) is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Leading global manufacturers of Sleeping Pills (Prescription Drugs) include Abbott Laboratories, Takeda Pharmaceutical, Sanofi, Hayao, Cayman Chemical, Aurobindo Pharma, Apotex, Ambitropin and Allegiant Health, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.

This report provides an overview of the global Sleeping Pills (Prescription Drugs) market in terms of sales, revenue, and price, analyzing global market trends using historical revenue and sales data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.

The study covers key producers of Sleeping Pills (Prescription Drugs) and sales in major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.

The report also presents Sleeping Pills (Prescription Drugs) sales, revenue, market share, and industry ranking for the main manufacturers for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.

In addition, the report analyzes segment data by Type and Application—covering sales, revenue, and price—for 2021-2032, and evaluates and forecasts the Sleeping Pills (Prescription Drugs) market size, projected growth trends, production technologies, key applications, and end-use industries.

Sleeping Pills (Prescription Drugs) Segment by Company

Abbott Laboratories

Takeda Pharmaceutical

Sanofi

Hayao

Cayman Chemical

Aurobindo Pharma

Apotex

Ambitropin

Allegiant Health

Actellon Pharmaceuticals

Sleeping Pills (Prescription Drugs) Segment by Type

Adapin (doxepin)

Ativan (lorazepam)

Ramelteon (Rozerem)

Eszopiclone (Lunesta)

Zolpidem

Sleeping Pills (Prescription Drugs) Segment by Application

Hospital Pharmacy

Retail Pharmacy

Sleeping Pills (Prescription Drugs) Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Study Objectives

1. To analyze and research the global status and future forecast, involving, production, value, consumption, growth rate (CAGR), market share, historical and forecast.

2. To present the key manufacturers, capacity, production, revenue, market share, and Recent Developments.

3. To split the breakdown data by regions, type, manufacturers, and Application.

4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify significant trends, drivers, influence factors in global and regions.

6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Sleeping Pills (Prescription Drugs) market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Sleeping Pills (Prescription Drugs) and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Sleeping Pills (Prescription Drugs).

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Provides an overview of the Sleeping Pills (Prescription Drugs) market, including product definition, global market growth prospects, market size, sales, and average price forecasts (2021-2032).

Chapter 2: Provides the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 3: Detailed analysis of Sleeping Pills (Prescription Drugs) manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, etc.

Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 6: Sales of Sleeping Pills (Prescription Drugs) in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space of each country in the world.

Chapter 7: Revenue of Sleeping Pills (Prescription Drugs) in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space of each country in the world.

Chapter 8: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.

Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.

Chapter 10: Concluding Insights of the report

More report detail

Tables and figures
List of Tables Table 1. Sleeping Pills (Prescription Drugs) Industry Trends Table 2. Sleeping Pills (Prescription Drugs) Industry Drivers Table 3. Sleeping Pills (Prescription Drugs) Industry Opportunities and Challenges Table 4. Sleeping Pills (Prescription Drugs) Industry Restraints Table 5. Global Sleeping Pills (Prescription Drugs) Revenue by Manufacturers (US$ Million) & (2021-2026) Table 6. Global Sleeping Pills (Prescription Drugs) Revenue Market Share by Manufacturers (2021-2026) Table 7. Global Sleeping Pills (Prescription Drugs) Sales by Manufacturers (M Units) & (2021-2026) Table 8. Global Sleeping Pills (Prescription Drugs) Sales Market Share by Manufacturers Table 9. Global Sleeping Pills (Prescription Drugs) Average Sales Price (US$/Unit) of Manufacturers (2021-2026) Table 10. Global Sleeping Pills (Prescription Drugs) Industry Manufacturers Ranking, 2024 VS 2025 VS 2026 Table 11. Global Sleeping Pills (Prescription Drugs) Key Manufacturers Manufacturing Sites & Headquarters Table 12. Global Sleeping Pills (Prescription Drugs) Manufacturers, Product Type & Application Table 13. Global Sleeping Pills (Prescription Drugs) Manufacturers Establishment Date Table 14. Global Manufacturers Market Concentration Ratio (CR5 and HHI) Table 15. Global Sleeping Pills (Prescription Drugs) by Manufacturers Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue of 2025) Table 16. Major Manufacturers of Adapin (doxepin) Table 17. Major Manufacturers of Ativan (lorazepam) Table 18. Major Manufacturers of Ramelteon (Rozerem) Table 19. Major Manufacturers of Eszopiclone (Lunesta) Table 20. Major Manufacturers of Zolpidem Table 21. Global Sleeping Pills (Prescription Drugs) Sales by Type 2021 VS 2025 VS 2032 (M Units) Table 22. Global Sleeping Pills (Prescription Drugs) Sales by Type (2021-2026) & (M Units) Table 23. Global Sleeping Pills (Prescription Drugs) Sales by Type (2027-2032) & (M Units) Table 24. Global Sleeping Pills (Prescription Drugs) Sales Market Share by Type (2021-2026) Table 25. Global Sleeping Pills (Prescription Drugs) Sales Market Share by Type (2027-2032) Table 26. Global Sleeping Pills (Prescription Drugs) Revenue by Type 2021 VS 2025 VS 2032 (M Units) Table 27. Global Sleeping Pills (Prescription Drugs) Revenue by Type (2021-2026) & (M Units) Table 28. Global Sleeping Pills (Prescription Drugs) Revenue by Type (2027-2032) & (M Units) Table 29. Global Sleeping Pills (Prescription Drugs) Revenue Market Share by Type (2021-2026) Table 30. Global Sleeping Pills (Prescription Drugs) Revenue Market Share by Type (2027-2032) Table 31. Major Manufacturers of Hospital Pharmacy Table 32. Major Manufacturers of Retail Pharmacy Table 33. Global Sleeping Pills (Prescription Drugs) Sales by Application 2021 VS 2025 VS 2032 (M Units) Table 34. Global Sleeping Pills (Prescription Drugs) Sales by Application (2021-2026) & (M Units) Table 35. Global Sleeping Pills (Prescription Drugs) Sales by Application (2027-2032) & (M Units) Table 36. Global Sleeping Pills (Prescription Drugs) Sales Market Share by Application (2021-2026) Table 37. Global Sleeping Pills (Prescription Drugs) Sales Market Share by Application (2027-2032) Table 38. Global Sleeping Pills (Prescription Drugs) Revenue by Application 2021 VS 2025 VS 2032 (M Units) Table 39. Global Sleeping Pills (Prescription Drugs) Revenue by Application (2021-2026) & (M Units) Table 40. Global Sleeping Pills (Prescription Drugs) Revenue by Application (2027-2032) & (M Units) Table 41. Global Sleeping Pills (Prescription Drugs) Revenue Market Share by Application (2021-2026) Table 42. Global Sleeping Pills (Prescription Drugs) Revenue Market Share by Application (2027-2032) Table 43. Global Sleeping Pills (Prescription Drugs) Sales by Region: 2021 VS 2025 VS 2032 (M Units) Table 44. Global Sleeping Pills (Prescription Drugs) Sales by Region (2021-2026) & (M Units) Table 45. Global Sleeping Pills (Prescription Drugs) Sales Market Share by Region (2021-2026) Table 46. Global Sleeping Pills (Prescription Drugs) Sales Forecasted by Region (2027-2032) & (M Units) Table 47. Global Sleeping Pills (Prescription Drugs) Sales Forecasted Market Share by Region (2027-2032) Table 48. North America Sleeping Pills (Prescription Drugs) Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (M Units) Table 49. North America Sleeping Pills (Prescription Drugs) Sales by Country (2021-2026) & (M Units) Table 50. North America Sleeping Pills (Prescription Drugs) Sales by Country (2027-2032) & (M Units) Table 51. Europe Sleeping Pills (Prescription Drugs) Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (M Units) Table 52. Europe Sleeping Pills (Prescription Drugs) Sales by Country (2021-2026) & (M Units) Table 53. Europe Sleeping Pills (Prescription Drugs) Sales by Country (2027-2032) & (M Units) Table 54. Asia Pacific Sleeping Pills (Prescription Drugs) Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (M Units) Table 55. Asia Pacific Sleeping Pills (Prescription Drugs) Sales by Country (2021-2026) & (M Units) Table 56. Asia Pacific Sleeping Pills (Prescription Drugs) Sales by Country (2027-2032) & (M Units) Table 57. South America, Middle East and Africa Sleeping Pills (Prescription Drugs) Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (M Units) Table 58. South America, Middle East and Africa Sleeping Pills (Prescription Drugs) Sales by Country (2021-2026) & (M Units) Table 59. South America, Middle East and Africa Sleeping Pills (Prescription Drugs) Sales by Country (2027-2032) & (M Units) Table 60. Global Sleeping Pills (Prescription Drugs) Revenue Grow Rate (CAGR) by Region: 2021 VS 2025 VS 2032 (US$ Million) Table 61. Global Sleeping Pills (Prescription Drugs) Revenue by Region (2021-2026) & (US$ Million) Table 62. Global Sleeping Pills (Prescription Drugs) Revenue by Region (2027-2032) & (US$ Million) Table 63. Global Sleeping Pills (Prescription Drugs) Revenue Market Share by Region (2021-2026) Table 64. Global Sleeping Pills (Prescription Drugs) Revenue Market Share by Region (2027-2032) Table 65. Abbott Laboratories Company Information Table 66. Abbott Laboratories Business Overview Table 67. Abbott Laboratories Sleeping Pills (Prescription Drugs) Sales (M Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 68. Abbott Laboratories Sleeping Pills (Prescription Drugs) Product Portfolio Table 69. Abbott Laboratories Recent Development Table 70. Takeda Pharmaceutical Company Information Table 71. Takeda Pharmaceutical Business Overview Table 72. Takeda Pharmaceutical Sleeping Pills (Prescription Drugs) Sales (M Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 73. Takeda Pharmaceutical Sleeping Pills (Prescription Drugs) Product Portfolio Table 74. Takeda Pharmaceutical Recent Development Table 75. Sanofi Company Information Table 76. Sanofi Business Overview Table 77. Sanofi Sleeping Pills (Prescription Drugs) Sales (M Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 78. Sanofi Sleeping Pills (Prescription Drugs) Product Portfolio Table 79. Sanofi Recent Development Table 80. Hayao Company Information Table 81. Hayao Business Overview Table 82. Hayao Sleeping Pills (Prescription Drugs) Sales (M Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 83. Hayao Sleeping Pills (Prescription Drugs) Product Portfolio Table 84. Hayao Recent Development Table 85. Cayman Chemical Company Information Table 86. Cayman Chemical Business Overview Table 87. Cayman Chemical Sleeping Pills (Prescription Drugs) Sales (M Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 88. Cayman Chemical Sleeping Pills (Prescription Drugs) Product Portfolio Table 89. Cayman Chemical Recent Development Table 90. Aurobindo Pharma Company Information Table 91. Aurobindo Pharma Business Overview Table 92. Aurobindo Pharma Sleeping Pills (Prescription Drugs) Sales (M Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 93. Aurobindo Pharma Sleeping Pills (Prescription Drugs) Product Portfolio Table 94. Aurobindo Pharma Recent Development Table 95. Apotex Company Information Table 96. Apotex Business Overview Table 97. Apotex Sleeping Pills (Prescription Drugs) Sales (M Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 98. Apotex Sleeping Pills (Prescription Drugs) Product Portfolio Table 99. Apotex Recent Development Table 100. Ambitropin Company Information Table 101. Ambitropin Business Overview Table 102. Ambitropin Sleeping Pills (Prescription Drugs) Sales (M Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 103. Ambitropin Sleeping Pills (Prescription Drugs) Product Portfolio Table 104. Ambitropin Recent Development Table 105. Allegiant Health Company Information Table 106. Allegiant Health Business Overview Table 107. Allegiant Health Sleeping Pills (Prescription Drugs) Sales (M Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 108. Allegiant Health Sleeping Pills (Prescription Drugs) Product Portfolio Table 109. Allegiant Health Recent Development Table 110. Actellon Pharmaceuticals Company Information Table 111. Actellon Pharmaceuticals Business Overview Table 112. Actellon Pharmaceuticals Sleeping Pills (Prescription Drugs) Sales (M Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 113. Actellon Pharmaceuticals Sleeping Pills (Prescription Drugs) Product Portfolio Table 114. Actellon Pharmaceuticals Recent Development Table 115. Key Raw Materials Table 116. Raw Materials Key Suppliers Table 117. Sleeping Pills (Prescription Drugs) Distributors List Table 118. Sleeping Pills (Prescription Drugs) Customers List Table 119. Research Programs/Design for This Report Table 120. Authors List of This Report Table 121. Secondary Sources Table 122. Primary Sources List of Figures Figure 1. Sleeping Pills (Prescription Drugs) Product Image Figure 2. Global Sleeping Pills (Prescription Drugs) Market Size (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Sleeping Pills (Prescription Drugs) Market Size (2021-2032) & (US$ Million) Figure 4. Global Sleeping Pills (Prescription Drugs) Sales (2021-2032) & (M Units) Figure 5. Global Sleeping Pills (Prescription Drugs) Average Price (US$/Unit) & (2021-2032) Figure 6. Global Top 5 and 10 Sleeping Pills (Prescription Drugs) Players Market Share by Revenue in 2025 Figure 7. Manufacturers Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 8. Adapin (doxepin) Image Figure 9. Ativan (lorazepam) Image Figure 10. Ramelteon (Rozerem) Image Figure 11. Eszopiclone (Lunesta) Image Figure 12. Zolpidem Image Figure 13. Global Sleeping Pills (Prescription Drugs) Sales by Type (2021 VS 2025 VS 2032) & (M Units) Figure 14. Global Sleeping Pills (Prescription Drugs) Sales Market Share 2021 VS 2025 VS 2032 Figure 15. Global Sleeping Pills (Prescription Drugs) Sales Market Share by Type (2021-2032) Figure 16. Global Sleeping Pills (Prescription Drugs) Revenue by Type (2021 VS 2025 VS 2032) & (M Units) Figure 17. Global Sleeping Pills (Prescription Drugs) Revenue Market Share 2021 VS 2025 VS 2032 Figure 18. Global Sleeping Pills (Prescription Drugs) Revenue Market Share by Type (2021-2032) Figure 19. Hospital Pharmacy Image Figure 20. Retail Pharmacy Image Figure 21. Global Sleeping Pills (Prescription Drugs) Sales by Application (2021 VS 2025 VS 2032) & (M Units) Figure 22. Global Sleeping Pills (Prescription Drugs) Sales Market Share 2021 VS 2025 VS 2032 Figure 23. Global Sleeping Pills (Prescription Drugs) Sales Market Share by Application (2021-2032) Figure 24. Global Sleeping Pills (Prescription Drugs) Revenue by Application (2021 VS 2025 VS 2032) & (M Units) Figure 25. Global Sleeping Pills (Prescription Drugs) Revenue Market Share 2021 VS 2025 VS 2032 Figure 26. Global Sleeping Pills (Prescription Drugs) Revenue Market Share by Application (2021-2032) Figure 27. North America Sleeping Pills (Prescription Drugs) Sales and Growth Rate (2021-2032) & (M Units) Figure 28. North America Sleeping Pills (Prescription Drugs) Sales Market Share by Country (2021-2032) Figure 29. U.S. Sleeping Pills (Prescription Drugs) Sales and Growth Rate (2021-2032) & (M Units) Figure 30. Canada Sleeping Pills (Prescription Drugs) Sales and Growth Rate (2021-2032) & (M Units) Figure 31. Mexico Sleeping Pills (Prescription Drugs) Sales and Growth Rate (2021-2032) & (M Units) Figure 32. Europe Sleeping Pills (Prescription Drugs) Sales and Growth Rate (2021-2032) & (M Units) Figure 33. Europe Sleeping Pills (Prescription Drugs) Sales Market Share by Country (2021-2032) Figure 34. Germany Sleeping Pills (Prescription Drugs) Sales and Growth Rate (2021-2032) & (M Units) Figure 35. France Sleeping Pills (Prescription Drugs) Sales and Growth Rate (2021-2032) & (M Units) Figure 36. U.K. Sleeping Pills (Prescription Drugs) Sales and Growth Rate (2021-2032) & (M Units) Figure 37. Italy Sleeping Pills (Prescription Drugs) Sales and Growth Rate (2021-2032) & (M Units) Figure 38. Netherlands Sleeping Pills (Prescription Drugs) Sales and Growth Rate (2021-2032) & (M Units) Figure 39. Asia Pacific Sleeping Pills (Prescription Drugs) Sales and Growth Rate (2021-2032) & (M Units) Figure 40. Asia Pacific Sleeping Pills (Prescription Drugs) Sales Market Share by Country (2021-2032) Figure 41. China Sleeping Pills (Prescription Drugs) Sales and Growth Rate (2021-2032) & (M Units) Figure 42. Japan Sleeping Pills (Prescription Drugs) Sales and Growth Rate (2021-2032) & (M Units) Figure 43. South Korea Sleeping Pills (Prescription Drugs) Sales and Growth Rate (2021-2032) & (M Units) Figure 44. Southeast Asia Sleeping Pills (Prescription Drugs) Sales and Growth Rate (2021-2032) & (M Units) Figure 45. India Sleeping Pills (Prescription Drugs) Sales and Growth Rate (2021-2032) & (M Units) Figure 46. Australia Sleeping Pills (Prescription Drugs) Sales and Growth Rate (2021-2032) & (M Units) Figure 47. South America, Middle East and Africa Sleeping Pills (Prescription Drugs) Sales and Growth Rate (2021-2032) & (M Units) Figure 48. South America, Middle East and Africa Sleeping Pills (Prescription Drugs) Sales Market Share by Country (2021-2032) Figure 49. Brazil Sleeping Pills (Prescription Drugs) Sales and Growth Rate (2021-2032) & (M Units) Figure 50. South Africa Sleeping Pills (Prescription Drugs) Sales and Growth Rate (2021-2032) & (M Units) Figure 51. Saudi Arabia Sleeping Pills (Prescription Drugs) Sales and Growth Rate (2021-2032) & (M Units) Figure 52. Turkey Sleeping Pills (Prescription Drugs) Sales and Growth Rate (2021-2032) & (M Units) Figure 53. Argentina Sleeping Pills (Prescription Drugs) Sales and Growth Rate (2021-2032) & (M Units) Figure 54. UAE Sleeping Pills (Prescription Drugs) Sales and Growth Rate (2021-2032) & (M Units) Figure 55. Egypt Sleeping Pills (Prescription Drugs) Sales and Growth Rate (2021-2032) & (M Units) Figure 56. Chile Sleeping Pills (Prescription Drugs) Sales and Growth Rate (2021-2032) & (M Units) Figure 57. Global Sleeping Pills (Prescription Drugs) Revenue (CAGR) by Region: 2021 VS 2025 VS 2032 (US$ Million) Figure 58. Global Sleeping Pills (Prescription Drugs) Revenue Market Share by Region in Percentage: 2025 Versus 2032 Figure 59. North America Sleeping Pills (Prescription Drugs) Revenue (2021-2032) & (US$ Million) Figure 60. North America Sleeping Pills (Prescription Drugs) Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 61. Europe Sleeping Pills (Prescription Drugs) Revenue (2021-2032) & (US$ Million) Figure 62. Europe Sleeping Pills (Prescription Drugs) Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 63. Asia-Pacific Sleeping Pills (Prescription Drugs) Revenue (2021-2032) & (US$ Million) Figure 64. Asia-Pacific Sleeping Pills (Prescription Drugs) Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 65. South America, Middle East and Africa Sleeping Pills (Prescription Drugs) Revenue (2021-2032) & (US$ Million) Figure 66. South America, Middle East and Africa Sleeping Pills (Prescription Drugs) Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 67. Sleeping Pills (Prescription Drugs) Value Chain Figure 68. Manufacturing Cost Structure Figure 69. Sleeping Pills (Prescription Drugs) Production Mode & Process Figure 70. Direct Comparison with Distribution Share Figure 71. Distributors Profiles Figure 72. Years Considered Figure 73. Research Process Figure 74. Key Executives Interviewed

Scope & coverage.

Types
  • Adapin (doxepin)
  • Ativan (lorazepam)
  • Ramelteon (Rozerem)
  • Eszopiclone (Lunesta)
  • Zolpidem
Applications
  • Hospital Pharmacy
  • Retail Pharmacy
Companies covered
  • Abbott Laboratories
  • Takeda Pharmaceutical
  • Sanofi
  • Hayao
  • Cayman Chemical
  • Aurobindo Pharma
  • Apotex
  • Ambitropin
  • Allegiant Health
  • Actellon Pharmaceuticals

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Sleeping Pills (Prescription Drugs) Market Size, 2021 VS 2025 VS 2032
  3. 1.3 Global Sleeping Pills (Prescription Drugs) Market Size Estimates and Forecasts (2021-2032)
  4. 1.4 Global Sleeping Pills (Prescription Drugs) Sales Estimates and Forecasts (2021-2032)
  5. 1.5 Global Sleeping Pills (Prescription Drugs) Market Average Price (2021-2032)
  6. 1.6 Assumptions and Limitations
  7. 1.7 Study Goals and Objectives
2 Global Sleeping Pills (Prescription Drugs) Market Dynamics
  1. 2.1 Sleeping Pills (Prescription Drugs) Industry Trends
  2. 2.2 Sleeping Pills (Prescription Drugs) Industry Drivers
  3. 2.3 Sleeping Pills (Prescription Drugs) Industry Opportunities and Challenges
  4. 2.4 Sleeping Pills (Prescription Drugs) Industry Restraints
3 Sleeping Pills (Prescription Drugs) Market by Manufacturers
  1. 3.1 Global Sleeping Pills (Prescription Drugs) Revenue by Manufacturers (2021-2026)
  2. 3.2 Global Sleeping Pills (Prescription Drugs) Sales by Manufacturers (2021-2026)
  3. 3.3 Global Sleeping Pills (Prescription Drugs) Average Sales Price by Manufacturers (2021-2026)
  4. 3.4 Global Sleeping Pills (Prescription Drugs) Industry Manufacturers Ranking, 2024 VS 2025 VS 2026
  5. 3.5 Global Sleeping Pills (Prescription Drugs) Key Manufacturers Manufacturing Sites & Headquarters
  6. 3.6 Global Sleeping Pills (Prescription Drugs) Manufacturers, Product Type & Application
  7. 3.7 Global Sleeping Pills (Prescription Drugs) Manufacturers Establishment Date
  8. 3.8 Market Competitive Analysis
  9. 3.8.1 Global Sleeping Pills (Prescription Drugs) Market CR5 and HHI
  10. 3.8.2 Global Top 5 and 10 Sleeping Pills (Prescription Drugs) Players Market Share by Revenue in 2025
  11. 3.8.3 2025 Sleeping Pills (Prescription Drugs) Tier 1, Tier 2, and Tier 3
4 Sleeping Pills (Prescription Drugs) Market by Type
  1. 4.1 Sleeping Pills (Prescription Drugs) Type Introduction
  2. 4.1.1 Adapin (doxepin)
  3. 4.1.2 Ativan (lorazepam)
  4. 4.1.3 Ramelteon (Rozerem)
  5. 4.1.4 Eszopiclone (Lunesta)
  6. 4.1.5 Zolpidem
  7. 4.2 Global Sleeping Pills (Prescription Drugs) Sales by Type
  8. 4.2.1 Global Sleeping Pills (Prescription Drugs) Sales by Type (2021 VS 2025 VS 2032)
  9. 4.2.2 Global Sleeping Pills (Prescription Drugs) Sales by Type (2021-2032)
  10. 4.2.3 Global Sleeping Pills (Prescription Drugs) Sales Market Share by Type (2021-2032)
  11. 4.3 Global Sleeping Pills (Prescription Drugs) Revenue by Type
  12. 4.3.1 Global Sleeping Pills (Prescription Drugs) Revenue by Type (2021 VS 2025 VS 2032)
  13. 4.3.2 Global Sleeping Pills (Prescription Drugs) Revenue by Type (2021-2032)
  14. 4.3.3 Global Sleeping Pills (Prescription Drugs) Revenue Market Share by Type (2021-2032)
5 Sleeping Pills (Prescription Drugs) Market by Application
  1. 5.1 Sleeping Pills (Prescription Drugs) Application Introduction
  2. 5.1.1 Hospital Pharmacy
  3. 5.1.2 Retail Pharmacy
  4. 5.2 Global Sleeping Pills (Prescription Drugs) Sales by Application
  5. 5.2.1 Global Sleeping Pills (Prescription Drugs) Sales by Application (2021 VS 2025 VS 2032)
  6. 5.2.2 Global Sleeping Pills (Prescription Drugs) Sales by Application (2021-2032)
  7. 5.2.3 Global Sleeping Pills (Prescription Drugs) Sales Market Share by Application (2021-2032)
  8. 5.3 Global Sleeping Pills (Prescription Drugs) Revenue by Application
  9. 5.3.1 Global Sleeping Pills (Prescription Drugs) Revenue by Application (2021 VS 2025 VS 2032)
  10. 5.3.2 Global Sleeping Pills (Prescription Drugs) Revenue by Application (2021-2032)
  11. 5.3.3 Global Sleeping Pills (Prescription Drugs) Revenue Market Share by Application (2021-2032)
6 Global Sleeping Pills (Prescription Drugs) Sales by Region
  1. 6.1 Global Sleeping Pills (Prescription Drugs) Sales by Region: 2021 VS 2025 VS 2032
  2. 6.2 Global Sleeping Pills (Prescription Drugs) Sales by Region (2021-2032)
  3. 6.2.1 Global Sleeping Pills (Prescription Drugs) Sales by Region (2021-2026)
  4. 6.2.2 Global Sleeping Pills (Prescription Drugs) Sales Forecasted by Region (2027-2032)
  5. 6.3 North America
  6. 6.3.1 North America Sleeping Pills (Prescription Drugs) Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  7. 6.3.2 North America Sleeping Pills (Prescription Drugs) Sales by Country (2021-2032)
  8. 6.3.3 U.S.
  9. 6.3.4 Canada
  10. 6.3.5 Mexico
  11. 6.4 Europe
  12. 6.4.1 Europe Sleeping Pills (Prescription Drugs) Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  13. 6.4.2 Europe Sleeping Pills (Prescription Drugs) Sales by Country (2021-2032)
  14. 6.4.3 Germany
  15. 6.4.4 France
  16. 6.4.5 U.K.
  17. 6.4.6 Italy
  18. 6.4.7 Netherlands
  19. 6.5 Asia Pacific
  20. 6.5.1 Asia Pacific Sleeping Pills (Prescription Drugs) Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  21. 6.5.2 Asia Pacific Sleeping Pills (Prescription Drugs) Sales by Country (2021-2032)
  22. 6.5.3 China
  23. 6.5.4 Japan
  24. 6.5.5 South Korea
  25. 6.5.6 Southeast Asia
  26. 6.5.7 India
  27. 6.5.8 Australia
  28. 6.6 South America, Middle East and Africa
  29. 6.6.1 South America, Middle East and Africa Sleeping Pills (Prescription Drugs) Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  30. 6.6.2 South America, Middle East and Africa Sleeping Pills (Prescription Drugs) Sales by Country (2021-2032)
  31. 6.6.3 Brazil
  32. 6.6.4 South Africa
  33. 6.6.5 Saudi Arabia
  34. 6.6.6 Turkey
  35. 6.6.6 Argentina
  36. 6.6.6 UAE
  37. 6.6.6 Egypt
  38. 6.6.6 Chile
7 Global Sleeping Pills (Prescription Drugs) Revenue by Region
  1. 7.1 Global Sleeping Pills (Prescription Drugs) Revenue by Region
  2. 7.1.1 Global Sleeping Pills (Prescription Drugs) Revenue by Region: 2021 VS 2025 VS 2032
  3. 7.1.2 Global Sleeping Pills (Prescription Drugs) Revenue by Region (2021-2026)
  4. 7.1.3 Global Sleeping Pills (Prescription Drugs) Revenue by Region (2027-2032)
  5. 7.1.4 Global Sleeping Pills (Prescription Drugs) Revenue Market Share by Region (2021-2032)
  6. 7.2 North America
  7. 7.2.1 North America Sleeping Pills (Prescription Drugs) Revenue (2021-2032)
  8. 7.2.2 North America Sleeping Pills (Prescription Drugs) Revenue Share by Country: 2021 VS 2025 VS 2032
  9. 7.3 Europe
  10. 7.3.1 Europe Sleeping Pills (Prescription Drugs) Revenue (2021-2032)
  11. 7.3.2 Europe Sleeping Pills (Prescription Drugs) Revenue Share by Country: 2021 VS 2025 VS 2032
  12. 7.4 Asia-Pacific
  13. 7.4.1 Asia-Pacific Sleeping Pills (Prescription Drugs) Revenue (2021-2032)
  14. 7.4.2 Asia-Pacific Sleeping Pills (Prescription Drugs) Revenue Share by Country: 2021 VS 2025 VS 2032
  15. 7.5 South America, Middle East and Africa
  16. 7.5.1 South America, Middle East and Africa Sleeping Pills (Prescription Drugs) Revenue (2021-2032)
  17. 7.5.2 South America, Middle East and Africa Sleeping Pills (Prescription Drugs) Revenue Share by Country: 2021 VS 2025 VS 2032
8 Company Profiles
  1. 8.1 Abbott Laboratories
  2. 8.1.1 Abbott Laboratories Company Information
  3. 8.1.2 Abbott Laboratories Business Overview
  4. 8.1.3 Abbott Laboratories Sleeping Pills (Prescription Drugs) Sales, Price, Revenue and Gross Margin (2021-2026)
  5. 8.1.4 Abbott Laboratories Sleeping Pills (Prescription Drugs) Product Portfolio
  6. 8.1.5 Abbott Laboratories Recent Developments
  7. 8.2 Takeda Pharmaceutical
  8. 8.2.1 Takeda Pharmaceutical Company Information
  9. 8.2.2 Takeda Pharmaceutical Business Overview
  10. 8.2.3 Takeda Pharmaceutical Sleeping Pills (Prescription Drugs) Sales, Price, Revenue and Gross Margin (2021-2026)
  11. 8.2.4 Takeda Pharmaceutical Sleeping Pills (Prescription Drugs) Product Portfolio
  12. 8.2.5 Takeda Pharmaceutical Recent Developments
  13. 8.3 Sanofi
  14. 8.3.1 Sanofi Company Information
  15. 8.3.2 Sanofi Business Overview
  16. 8.3.3 Sanofi Sleeping Pills (Prescription Drugs) Sales, Price, Revenue and Gross Margin (2021-2026)
  17. 8.3.4 Sanofi Sleeping Pills (Prescription Drugs) Product Portfolio
  18. 8.3.5 Sanofi Recent Developments
  19. 8.4 Hayao
  20. 8.4.1 Hayao Company Information
  21. 8.4.2 Hayao Business Overview
  22. 8.4.3 Hayao Sleeping Pills (Prescription Drugs) Sales, Price, Revenue and Gross Margin (2021-2026)
  23. 8.4.4 Hayao Sleeping Pills (Prescription Drugs) Product Portfolio
  24. 8.4.5 Hayao Recent Developments
  25. 8.5 Cayman Chemical
  26. 8.5.1 Cayman Chemical Company Information
  27. 8.5.2 Cayman Chemical Business Overview
  28. 8.5.3 Cayman Chemical Sleeping Pills (Prescription Drugs) Sales, Price, Revenue and Gross Margin (2021-2026)
  29. 8.5.4 Cayman Chemical Sleeping Pills (Prescription Drugs) Product Portfolio
  30. 8.5.5 Cayman Chemical Recent Developments
  31. 8.6 Aurobindo Pharma
  32. 8.6.1 Aurobindo Pharma Company Information
  33. 8.6.2 Aurobindo Pharma Business Overview
  34. 8.6.3 Aurobindo Pharma Sleeping Pills (Prescription Drugs) Sales, Price, Revenue and Gross Margin (2021-2026)
  35. 8.6.4 Aurobindo Pharma Sleeping Pills (Prescription Drugs) Product Portfolio
  36. 8.6.5 Aurobindo Pharma Recent Developments
  37. 8.7 Apotex
  38. 8.7.1 Apotex Company Information
  39. 8.7.2 Apotex Business Overview
  40. 8.7.3 Apotex Sleeping Pills (Prescription Drugs) Sales, Price, Revenue and Gross Margin (2021-2026)
  41. 8.7.4 Apotex Sleeping Pills (Prescription Drugs) Product Portfolio
  42. 8.7.5 Apotex Recent Developments
  43. 8.8 Ambitropin
  44. 8.8.1 Ambitropin Company Information
  45. 8.8.2 Ambitropin Business Overview
  46. 8.8.3 Ambitropin Sleeping Pills (Prescription Drugs) Sales, Price, Revenue and Gross Margin (2021-2026)
  47. 8.8.4 Ambitropin Sleeping Pills (Prescription Drugs) Product Portfolio
  48. 8.8.5 Ambitropin Recent Developments
  49. 8.9 Allegiant Health
  50. 8.9.1 Allegiant Health Company Information
  51. 8.9.2 Allegiant Health Business Overview
  52. 8.9.3 Allegiant Health Sleeping Pills (Prescription Drugs) Sales, Price, Revenue and Gross Margin (2021-2026)
  53. 8.9.4 Allegiant Health Sleeping Pills (Prescription Drugs) Product Portfolio
  54. 8.9.5 Allegiant Health Recent Developments
  55. 8.10 Actellon Pharmaceuticals
  56. 8.10.1 Actellon Pharmaceuticals Company Information
  57. 8.10.2 Actellon Pharmaceuticals Business Overview
  58. 8.10.3 Actellon Pharmaceuticals Sleeping Pills (Prescription Drugs) Sales, Price, Revenue and Gross Margin (2021-2026)
  59. 8.10.4 Actellon Pharmaceuticals Sleeping Pills (Prescription Drugs) Product Portfolio
  60. 8.10.5 Actellon Pharmaceuticals Recent Developments
9 Value Chain and Sales Channels Analysis
  1. 9.1 Sleeping Pills (Prescription Drugs) Value Chain Analysis
  2. 9.1.1 Sleeping Pills (Prescription Drugs) Key Raw Materials
  3. 9.1.2 Raw Materials Key Suppliers
  4. 9.1.3 Manufacturing Cost Structure
  5. 9.1.4 Sleeping Pills (Prescription Drugs) Production Mode & Process
  6. 9.2 Sleeping Pills (Prescription Drugs) Sales Channels Analysis
  7. 9.2.1 Direct Comparison with Distribution Share
  8. 9.2.2 Sleeping Pills (Prescription Drugs) Distributors
  9. 9.2.3 Sleeping Pills (Prescription Drugs) Customers
10 Concluding Insights
    11 Appendix
    1. 11.1 Reasons for Doing This Study
    2. 11.2 Research Methodology
    3. 11.3 Research Process
    4. 11.4 Authors List of This Report
    5. 11.5 Data Source
    6. 11.5.1 Secondary Sources
    7. 11.5.2 Primary Sources
    8. 11.6 Disclaimer

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $3,950USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst